Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Medicenna Therapeutics Corp (MDNA)

Medicenna Therapeutics Corp (MDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Could CRISPR Therapeutics Help You Become a Millionaire? Motley Fool - Tue Dec 27, 2022

The gene-editing stock still has plenty of promise.

CRSP : 46.73 (+0.41%)
VRTX : 479.00 (+0.34%)
MDNA : 0.1570 (-13.16%)
Medicenna Announces Closing of Public Offering of Units Raising US$20 Million to Advance Pipeline Globe Newswire - Thu Aug 11, 2022

TORONTO and HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)
Medicenna Announces Pricing of US$20 Million Public Offering of Units Globe Newswire - Tue Aug 9, 2022

TORONTO and HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)
Medicenna Announces the Launch of a Marketed Underwritten Public Offering of Units Globe Newswire - Mon Aug 8, 2022

TORONTO and HOUSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (Nasdaq: MDNA, TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)
Medicenna to Announce First Quarter Fiscal 2023 Financial Results and Operational Highlights on Monday, August 15, 2022 Globe Newswire - Fri Aug 5, 2022

TORONTO and HOUSTON, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or “the Company") (NASDAQ: MDNA TSX: MDNA), a clinical...

MDNA.TO : 0.3450 (-1.43%)
MDNA : 0.1570 (-13.16%)

Barchart Exclusives

Altria Stock: Why Q2 Matters for Its High-Yield Appeal Barchart - Mon Jul 27, 6:30PM CDT
Altria's Dividend King reputation faces another important test in the upcoming Q2 earnings report as investors look beyond its shrinking cigarette business. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.